TNYA is trading at 5.9% up now at $0.79 on light news flow, extending its recent multi-day upward drift from the low-$0.70s. With no fresh company announcements, earnings, or analyst calls reported so far, the move appears modest and likely reflects normal volatility in a low-priced biotech name amid a generally supportive broader market backdrop.